Skip to main content
. Author manuscript; available in PMC: 2017 Sep 6.
Published in final edited form as: Am J Gastroenterol. 2017 Apr 25;112(9):1389–1396. doi: 10.1038/ajg.2017.98

Table 4.

Characteristics of 19 ALI subjects who died within 21 days of enrollment

ALI etiology Progression
to ALF
Time from
enrollment to
death (days)
Cause of death
1. APAP No 2 Cardiac arrest
2. Hepatitis B Yes 3 Multisystem organ Failure/sepsis
3. Shock/ischemia Yes 11 Unknown
4. Autoimmune hepatitis Yes 16 Unknown
5. DILI Yes 8 Multisystem organ failure
6. APAP Yes 8 Neurological (cerebral edema)
7. Indeterminate No 1 Unknown
8. Indeterminate Yes 11 Neurological (cerebral edema)
9. APAP No 8 Pulmonary embolism
10. Autoimmune hepatitis Yes 7 Liver failure
11. Indeterminate Yes 4 Multisystem organ failure/sepsis
12. Autoimmune hepatitis No 13 Multisystem organ Failure
13. Autoimmune hepatitis Yes 4 PEA arrest
14. Shock/ischemia No 14 Multisystem organ failure
15. APAP No 10 Liver failure
16. Hepatitis B No 9 Liver failure
17. Indeterminate No 18 Unknown
18. Hepatitis B No 20 Liver failure
19. Autoimmune hepatitisa Yes 17 Intracardiac thrombosis

ALI, acute liver injury; ALF, acute liver failure; APAP, N-acetyl-p-aminophenol; DILI, drug-induced liver injury; PEA, pulseless electrical activity.

a

Patient died shortly after liver transplant.